A Comparison of Two Types of Injected Nutritional Supplements in Patients With AIDS and Pneumocystis Carinii Pneumonia (PCP)
HIV Infections
About this trial
This is an interventional treatment trial for HIV Infections focused on measuring Weight Loss, Pneumonia, Pneumocystis carinii, Parenteral Nutrition, Liposyn, Acquired Immunodeficiency Syndrome
Eligibility Criteria
Inclusion Criteria Concurrent Medication: Allowed: All drugs used for the standard treatment of Pneumocystis carinii pneumonia (PCP). Other drugs for treatment of other AIDS conditions if they have been started more than 3 months prior to study entry. Patients must have: Diagnosis of AIDS. Weight loss > 10 percent of premorbid body weight. First or second episode of acute Pneumocystis carinii pneumonia (PCP). Exclusion Criteria Co-existing Condition: Patients with the following conditions or symptoms are excluded: Do Not Resuscitate (DNR) status. Biliary stasis. Patients with the following are excluded: Do Not Resuscitate (DNR) status. Biliary stasis. Prior Medication: Excluded within 3 months of study entry: Immunomodulators. Antiviral new DT
Sites / Locations
- East Orange Veterans Administration Med Ctr